Smartphone app "Smiling instead of Smoking" (SiS) Version 3 for Smoke

Phase-Based Progress Estimates
Smartphone app "Smiling instead of Smoking" (SiS) Version 3 - Behavioral
All Sexes
What conditions do you have?

Study Summary

This trial is testing whether a new smartphone app (SiS) can help people quit smoking, compared to the current best app (QG) or just receiving usual care (TAU).

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 12 Secondary · Reporting Duration: up to 24 weeks post quit day

Assessed at treatment end (6-week)
App usability ratings (SiS and QG only)
Likability rating of the app (SiS and QG only)
Perceived impact of the provided materials on quitting
Satisfaction rating of the smoking cessation support (SiS and QG only)
Satisfaction with smoking cessation support
Time spent applying content brought up by the apps/"Clearing the Air"
Use of smoking cessation strategies
Week 24
Actual app usage (SiS and QG only)
Self-reported 30-day point-prevalence abstinence
Self-reported past week cigarette change
Smoking Self-Efficacy Questionnaire (SEQ)
Week 6
Self-reported app usage (SiS and QG only)

Trial Safety

Trial Design

2 Treatment Groups

1 of 2
1 of 2
Active Control
Experimental Treatment

228 Total Participants · 2 Treatment Groups

Primary Treatment: Smartphone app "Smiling instead of Smoking" (SiS) Version 3 · No Placebo Group · N/A

Experimental Group · 1 Intervention: Smartphone app "Smiling instead of Smoking" (SiS) Version 3 · Intervention Types: Behavioral
ActiveComparator Group · 1 Intervention: Smartphone app "QuitGuide" (QG) · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 24 weeks post quit day

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,673 Previous Clinical Trials
30,828,428 Total Patients Enrolled
Bettina Hoeppner, Ph.D., M.S.Principal InvestigatorMassachusetts General Hospital

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 8th, 2021

Last Reviewed: October 20th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.